Overall Score

Threat Of New Entrants

Moderate capital and product complexity create some barriers to entry in the imaging and healthcare equipment space.

XPER's strong gross margin of 71.4% suggests incumbents can sustain pricing power, but the low EV/Sales of 0.61x implies the market still sees limited moat protection.

Bargaining Power Of Suppliers

Supplier leverage appears manageable given the company's current ratio of 2.48x and cash ratio of 0.79x, which support procurement flexibility.

However, negative free cash flow and a cash conversion cycle of 85.3 days indicate working-capital pressure that can reduce sourcing flexibility.

Bargaining Power Of Buyers

Buyers likely retain meaningful negotiating power because XPER's net margin is -7.1% and operating margin is -2.4%, limiting the company's ability to absorb price pressure.

Still, the 71.4% gross margin and 13.9% EBITDA margin show the business can preserve healthy unit economics when demand is stable.

Threat Of Substitutes

Substitution risk remains moderate because the company operates in a specialized equipment niche where product performance and integration matter.

That said, weak profitability and a price-to-sales ratio of 0.66x suggest the market does not assign a strong differentiation premium.

Industry Rivalry

Rivalry is moderate-to-high given the company's thin EBIT margin of 0.3% and negative operating margin, which can intensify price competition.

The low valuation multiples and negative free cash flow also indicate a competitive environment where scale and execution remain critical.